Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Sarcomatous Kidney Cancer That is Metastatic in Adults With Doxorubicin and Ifosfamide. Phase II Study

NCT00003683 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00003683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Sarcomatous Kidney Cancer That is Metastatic in Adults With Doxorubicin and Ifosfamide. Phase II Study
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
March 31, 1998
Completion date
April 30, 2002
Enrollment
40 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer